<DOC>
	<DOCNO>NCT03054636</DOCNO>
	<brief_summary>The Short term Perfusion Angiography ( SPA ) study design collect 2D Perfusion data Critical Limb Ischemia ( CLI ) endovascular ( interventional ) procedures information device performance real-world setting .</brief_summary>
	<brief_title>Short-term Perfusion Angiography Pilot Study ( SPA )</brief_title>
	<detailed_description>This clinical study design collect pre post procedural imaging data use 2D Perfusion ( 2DP ) software patient receive endovascular intervention .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>1 . Subject &gt; 18 year age . 2 . Subject legally authorize representative understands research nature study willing capable providing inform consent 3 . Subject appropriate femoral arterial access 4 . Subject present Rutherford classification 4 6 . 5 . Subject schedule Digital Subtraction Angiography ( DSA ) endovascular intervention knee one limb . 1 . Subject unwilling unable comply protocol include followup visit 2 . Critical limb ischemia due acute arterial occlusion . 3 . Subject unwilling unable comply protocol 4 . Subjects history know reaction sensitivity contrast agent premedicated condition precludes endovascular intervention DSA 5 . Female subject childbearing potential pregnant ( must negative pregnancy test within 48 hour prior enrollment ) , plan pregnancy study period , 6 . Subject life expectancy &lt; 3 month , 7 . Subject participate potentially confound device drug clinical trial interferes study 8 . Investigator considers subject poor candidate study believe patient may compromise study , e.g. , concomitant condition ( reason document )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>